Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mitral regurgitation
MedTech
Capstan Medical nets $31M for robotic heart valve replacement
A startup that aims to integrate robotics with minimally invasive heart valve procedures has collected $31.4 million in venture capital funding.
Conor Hale
Aug 10, 2023 10:40am
TMVR maker 4C Medical scores $35M and a new CEO to boot
Mar 31, 2022 4:10pm
InnovHeart nabs J&J, Haemonetics alum as CEO
Mar 30, 2022 11:28am
InnovHeart lands $55M to take TMVR system to clinical trials
Jan 27, 2022 11:50am
Abbott nets EU approval for next-gen MitraClip
Sep 21, 2020 9:00am
Abbott nets CE mark for transcatheter mitral valve replacement
Jan 30, 2020 12:46pm